These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 30477459

  • 21. Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.
    Durante MA, Walter SD, Paez-Escamilla M, Tokarev J, Decatur CL, Dubovy SR, Schefler AC, Harbour JW.
    JAMA Ophthalmol; 2019 Dec 01; 137(12):1434-1439. PubMed ID: 31580399
    [Abstract] [Full Text] [Related]

  • 22. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
    Turunen JA, Markkinen S, Wilska R, Saarinen S, Raivio V, Täll M, Lehesjoki AE, Kivelä TT.
    Ophthalmology; 2016 May 01; 123(5):1112-7. PubMed ID: 26876698
    [Abstract] [Full Text] [Related]

  • 23. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Abdel-Rahman MH, Sample KM, Pilarski R, Walsh T, Grosel T, Kinnamon D, Boru G, Massengill JB, Schoenfield L, Kelly B, Gordon D, Johansson P, DeBenedictis MJ, Singh A, Casadei S, Davidorf FH, White P, Stacey AW, Scarth J, Fewings E, Tischkowitz M, King MC, Hayward NK, Cebulla CM.
    Ophthalmology; 2020 May 01; 127(5):668-678. PubMed ID: 32081490
    [Abstract] [Full Text] [Related]

  • 24. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L, Navrátilová M, Svoboda M, Házová J, Vašíčková P, Sťahlová EH, Fabian P, Schneiderová M, Macháčková E.
    Klin Onkol; 2019 May 01; 32(Supplementum2):118-122. PubMed ID: 31409087
    [Abstract] [Full Text] [Related]

  • 25. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF.
    Ophthalmic Genet; 2021 Dec 01; 42(6):732-743. PubMed ID: 34353217
    [Abstract] [Full Text] [Related]

  • 26. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
    Yavuzyigitoglu S, Mensink HW, Smit KN, Vaarwater J, Verdijk RM, Beverloo B, Brüggenwirth HT, van Marion R, Dubbink HJ, Paridaens D, Naus NC, de Klein A, Kiliç E, Rotterdam Ocular Melanoma Study Group (ROMS).
    Invest Ophthalmol Vis Sci; 2016 Apr 01; 57(4):2232-9. PubMed ID: 27116551
    [Abstract] [Full Text] [Related]

  • 27. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
    Martorano LM, Winkelmann RR, Cebulla CM, Abdel-Rahman MH, Campbell SM.
    Int J Dermatol; 2014 Jun 01; 53(6):657-63. PubMed ID: 24697775
    [Abstract] [Full Text] [Related]

  • 28. Oncologist-led germline genetic testing for uveal melanoma.
    Gillies B, Krema H, Chao A, Lando L, Farncombe KM, Butler M, Altomare F, Kim RH.
    Ophthalmic Genet; 2023 Jun 01; 44(3):253-261. PubMed ID: 36974392
    [Abstract] [Full Text] [Related]

  • 29. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
    Gupta S, Erickson LA, Lohse CM, Shen W, Pitel BA, Knight SM, Halling KC, Herrera-Hernandez L, Boorjian SA, Thompson RH, Leibovich BC, Jimenez RE, Cheville JC.
    JAMA Netw Open; 2021 Nov 01; 4(11):e2132615. PubMed ID: 34767027
    [Abstract] [Full Text] [Related]

  • 30. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
    Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H.
    PLoS One; 2012 Nov 01; 7(4):e35295. PubMed ID: 22545102
    [Abstract] [Full Text] [Related]

  • 31. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
    Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.
    J Natl Cancer Inst; 2018 Dec 01; 110(12):1328-1341. PubMed ID: 30517737
    [Abstract] [Full Text] [Related]

  • 32. Frequent mutation of BAP1 in metastasizing uveal melanomas.
    Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM.
    Science; 2010 Dec 03; 330(6009):1410-3. PubMed ID: 21051595
    [Abstract] [Full Text] [Related]

  • 33. Germline BAP1 mutations misreported as somatic based on tumor-only testing.
    Abdel-Rahman MH, Rai K, Pilarski R, Davidorf FH, Cebulla CM.
    Fam Cancer; 2016 Apr 03; 15(2):327-30. PubMed ID: 26748926
    [Abstract] [Full Text] [Related]

  • 34. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
    Yavuzyigitoglu S, Koopmans AE, Verdijk RM, Vaarwater J, Eussen B, van Bodegom A, Paridaens D, Kiliç E, de Klein A, Rotterdam Ocular Melanoma Study Group.
    Ophthalmology; 2016 May 03; 123(5):1118-28. PubMed ID: 26923342
    [Abstract] [Full Text] [Related]

  • 35. A population-based analysis of germline BAP1 mutations in melanoma.
    O'Shea SJ, Robles-Espinoza CD, McLellan L, Harrigan J, Jacq X, Hewinson J, Iyer V, Merchant W, Elliott F, Harland M, Bishop DT, Newton-Bishop JA, Adams DJ.
    Hum Mol Genet; 2017 Feb 15; 26(4):717-728. PubMed ID: 28062663
    [Abstract] [Full Text] [Related]

  • 36. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
    Haugh AM, Njauw CN, Bubley JA, Verzì AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P.
    JAMA Dermatol; 2017 Oct 01; 153(10):999-1006. PubMed ID: 28793149
    [Abstract] [Full Text] [Related]

  • 37. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL, Ong E, Garg N, Anbunathan H, Bowcock AM, Field MG, Harbour JW.
    JAMA Ophthalmol; 2016 Jul 01; 134(7):728-33. PubMed ID: 27123562
    [Abstract] [Full Text] [Related]

  • 38. Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.
    Star P, Goodwin A, Kapoor R, Conway RM, Long GV, Scolyer RA, Guitera P.
    Eur J Cancer; 2018 Mar 01; 92():48-53. PubMed ID: 29413689
    [Abstract] [Full Text] [Related]

  • 39. Germline BAP1 mutations predispose to malignant mesothelioma.
    Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M.
    Nat Genet; 2011 Aug 28; 43(10):1022-5. PubMed ID: 21874000
    [Abstract] [Full Text] [Related]

  • 40. Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of Risk.
    Singh N, Singh R, Bowen RC, Abdel-Rahman MH, Singh AD.
    Am J Ophthalmol; 2021 Apr 28; 224():172-177. PubMed ID: 33316260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.